1. Home
  2. YEXT vs MDXG Comparison

YEXT vs MDXG Comparison

Compare YEXT & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Yext Inc.

YEXT

Yext Inc.

HOLD

Current Price

$7.59

Market Cap

981.0M

Sector

Technology

ML Signal

HOLD

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

HOLD

Current Price

$5.43

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
YEXT
MDXG
Founded
2006
2006
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
981.0M
1.0B
IPO Year
2017
N/A

Fundamental Metrics

Financial Performance
Metric
YEXT
MDXG
Price
$7.59
$5.43
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$9.44
$11.00
AVG Volume (30 Days)
862.7K
931.7K
Earning Date
03-04-2026
02-25-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
0.27
Revenue
$447,666,000.00
$393,442,000.00
Revenue This Year
$8.66
$19.13
Revenue Next Year
$4.77
$2.11
P/E Ratio
$35.37
$20.07
Revenue Growth
9.46
14.77
52 Week Low
$5.51
$5.39
52 Week High
$9.20
$9.36

Technical Indicators

Market Signals
Indicator
YEXT
MDXG
Relative Strength Index (RSI) 30.84 21.91
Support Level $7.77 $5.55
Resistance Level $7.79 $6.50
Average True Range (ATR) 0.17 0.22
MACD -0.05 -0.11
Stochastic Oscillator 22.22 2.55

Price Performance

Historical Comparison
YEXT
MDXG

About YEXT Yext Inc.

Yext Inc provides a knowledge engine platform that lets businesses manage their digital knowledge in the cloud and sync it to approximately 200 services including Apple Maps, Bing, Cortana, Facebook, Google, Google Maps, Instagram, Siri and Yelp. Digital knowledge is the structured information that a business wants to make publicly accessible. The company also makes search intelligent by helping to provide precise, accurate and current answers to location-based queries that are conducted across the web and mobile applications and voice and artificial intelligence, or AI, engines. The company derives the majority of its revenues from subscription services. Geographically, the company generates a majority of its revenue from North America and the rest from International markets.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: